ITO 2.0 Guest Speaker Series
Lynn Buchanan, Ph.D.
Vice President, OCRI Life Sciences
ITO 2.0 West Ottawa Centre
Date: Thursday, July 9th, 2009
Time: 1:00 PM - 3:00 PM
Location: 301 Moodie Drive, Suite 102
Cost: Free
Parking: Free
If you are interested in the Life Sciences Industry, don't miss this
informative guest speaker, the Vice President of OCRI Life Sciences, Lynn
Buchanan, speak about the sector, local companies, employment trends,
technology skill requirements and the future of the industry. OCRI Life
Sciences is dedicated to providing the services needed to grow and support
the life sciences community in Ottawa and Eastern Ontario.
With a solid base of companies in the Life Science and Cleantech sectors,
two major universities (Carleton University and the University of Ottawa),
the National Research Council, over 40 research institutes/centres and
some of Canada's leading service providers, Ottawa is a thriving R&D,
clinical research and manufacturing centre. In addition, Eastern Ontario's
rural communities offer excellent greenfield locations for manufacturing,
integrated biomass conversion and agricultural technologies.
OCRI Life Sciences is a division of OCRI-the Ottawa Centre for Research
and Innovation. OCRI is a non-profit, partnership whose mission is to lead
Ottawa in economic development by connecting business, research,
education, government and talent to advance the competitiveness of our
knowledge-based industries and institutions, to build wealth and enhance
our quality of life.
About Lynn Buchanan
Dr. Lynn Buchanan is Vice President, Life Sciences at OCRI and brings
nearly 20 years of global research and senior management experience with
leading pharmaceutical and life sciences companies in Canada and the USA.
Lynn's background includes diverse scientific, regulatory and business
expertise in the development and commercialization of novel therapeutics,
diagnostics, medical devices and enabling technologies for translational
research and medicine. She has extensive experience establishing new
research programs and external partnerships with industry and academia to
successfully deliver leading edge technologies for drug discovery and
development, competitive advantage and new business opportunities.
Previously she was Chief Scientist, R&D at MDS Nordion, Head of
Experimental Pathology & Toxicology at Wyeth Research in New York, and
Scientific Director, In Vitro Toxicology & Metabolism at BioResearch
Laboratories Ltd. in Montreal.
Lynn holds a Ph.D. in Anatomy & Experimental Pathology from the University
of St. Andrews, U.K., and after completing a postdoctoral fellowship in
Pharmacology & Therapeutics at McGill University, she received an MRC
Biotechnology award for cancer research at Queen's University.